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Abstract 
 
In clinical settings, caregivers often report that medically related visits are often longer and 
more difficult for children with an Autism Spectrum Disorder (ASD). A preliminary study 
conducted by Dr. Robin Gabriels and Dr. John Agnew, indicated that picture schedules can 
reduce aberrant behaviors during a medical exam (R. Gabriels et al., 2013). The present project 
assessed whether a picture schedule reinforcement book can help reduce the stress 
experienced by children with ASD and diabetes during their routine blood draw. The Aberrant 
Behavior Checklist Community (ABC-C) was used to measure the subject’s irritability and 
stereotypic behaviors. The subjects displayed reduced irritability and stereotypic behaviors 
during the blood draw. The subjects also had a lower cooperation scale in the treatment blood 
draw than in their previous baseline blood draw. The limitation of this study was the low 
sample size (n=2) and comparing ABC-C scores that asked parents to scores behavior for 
different amount of time.  
 
  
- 5 - 
 
Introduction: 
Autistic disorder is a neurodevelopmental disorder within the broader category of 
Autism Spectrum Disorders (ASD) and is characterized by communication impairments, social 
skill impairments and restricted repetitive and stereotyped behavior (APA, 2000; WHO, 2004). 
ASD includes Autistic Disorder, Asperger’s Syndrome, and Pervasive Developmental Disorder 
Not Otherwise Specified (PDD-NOS)(APA, 2000; WHO, 2004). In recent years, the incidence of 
ASD has grown dramatically. The most recent estimates from data collected in 2008 
approximate that 1 in 88 eight year old children have an ASD (CDC, 2012). This number is higher 
than the CDC’s estimates from 2006 (1 in 111) and even higher than estimates from data 
collected in 2002 (1 in 156)(CDC, 2012). With the rise in ASD incidence, it is becoming 
increasingly important to identify effective treatment strategies for this population. 
Children with ASD have unique social-communication and behavior impairments that 
complicate their medical care. In clinical settings, caregivers and physicians report man 
challenges associated with treating patients with ASD (Brachlow, Ness, McPheeters, & Gurney, 
2007). Therefore, a basic premise of this study is that the addition of a picture schedule 
reinforcement system will help reduce stress during routine blood draw procedures as similar 
strategies have been used successfully with this population within the field of education (Bryan 
& Gast, 2000). As children with a dual diagnosis of diabetes and ASD receive regular blood 
draws, this specific population was sought out for the current study. If the strategy proposed in 
this study is successful, it could be generalized to provide primary care physicians with an 
approach to conduct more thorough and less challenging blood draws with their patients with 
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ASD. This strategy could also help decrease the time and cost of health care for children with 
ASD who require blood draws in a variety of medical and community settings.  
Background: 
Overview: 
In 1943, Dr. Leo Kanner was the first to describe the condition he termed infantile 
autism (Kanner, 1943). While the diagnostic criteria have changed over the years, his 
description of the symptomology is still an accurate description of the population. The 
diagnostic definition of autism includes a widerange of problems in three core areas: social, 
communication, and behavior. Within clinical practice in the United States today, two valid and 
reliable tools used in diagnosing children with ASD are the Autism Diagnostic Observation 
Schedule (ADOS) and the Autism Diagnostic Interview (ADI), which are based upon current 
diagnostic criteria in the DSM-IV-TR (de Bildt et al., 2004; Lord et al., 1989; Lord, Rutter, & Le 
Couteur, 1994). The ADOS is a semi-structured play based assessment of the child while the ADI 
is a semi-structured interview with the caregiver (Lord et al., 1989; Lord et al., 1994) 
 While the precise etiology of ASD is still unknown, there are many hypotheses that have 
received a great deal of attention over the years. Some of these hypotheses have been 
overdramatized by the media and subsequently proven wrong (mercury exposure, vaccinations, 
etc.), but many more have built up momentum within the scientific community as additional 
data has been garnered. Influences such as genetic factors, immunological factors and prenatal 
exposure to serotonin have all been described as having potential influence on the 
development of ASD symptoms (Coutinho et al., 2007; Jyonouchi, Geng, Cushing-Ruby, & 
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Quraishi, 2008; Jyonouchi, Geng, Streck, & Toruner, 2011; Kane et al., 2012; Levitt, 2011; 
Patterson, 2009, 2011; Persico, Van de Water, & Pardo, 2012; Rossignol & Frye, 2012; Sato, 
2013). It has also been proposed that preconceptional folic acid intake may reduce the risk of 
ASD for the child (Berry, Crider, & Yeargin-Allsopp, 2013; Schmidt et al., 2012; Surén et al., 
2013). However, it is important to note that no single factor has been proven conclusively to 
cause or prevent ASD.  
 Two pharmaceuticals (risperidone and aripiprazole) are currently approved by the FDA 
to treat ASD symptoms effectively in the United States but many more are used off-label 
(Canitano & Scandurra, 2008; Chadman, 2011; Ching & Pringsheim, 2012; Farmer & Aman, 
2011; Lemmon, Gregas, & Jeste, 2011; Rosenberg & Samuel, 2012; Valdovinos, Bailey, & Taylor, 
2010; Wei, Huang, Qin, & Liang, 2011). While pharmaceuticals have begun to raise the quality 
of life for individuals with an ASD, the majority of treatments also include behavioral therapies 
and/or interventions. Contemporary research has shown that early intensive intervention has 
the most beneficial effects on individuals with ASD (Rogers, 1996). Other interventions for ASD 
that have proved effective are Applied Behavioral Analysis (ABA) and Equine Assisted Activities 
and Therapy (EAAT) (Bass, Duchowny, & Llabre, 2009; Callahan, Shukla-Mehta, Magee, & Wie, 
2010; R. L. Gabriels et al., 2012; Ward, Whalon, Rusnak, Wendell, & Paschall, 2013). 
The intervention being used in this study is based on research done in picture schedules 
with the Treatment and Education of Autistic and Related Communication Handicapped 
Children (TEACCH) program. Within the dental field, studies have begun to show the efficacy of 
using TEACCH principles in dental settings to improve dental care for individuals with ASD 
(Bäckman & Pilebro, 1999a, 1999b; Cuvo, Godard, Huckfeldt, & DeMattei, 2010; Lowe & 
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Lindemann, 1985; Pilebro & Bäckman, 2005). Additionally, other studies have begun to show 
how procedures specifically using picture schedule reinforcement systems are effective tools 
within hospital settings (Chebuhar, McCarthy, & Bosch, 2012; R. Gabriels et al., 2013). 
Symptomology: 
 In 1943, Leo Kanner was the first to describe a group of children presenting with three 
common symptoms: impairments in communication, impairments in socialization, and 
repetitive and stereotyped behavior (Kanner, 1943). In his paper, Kanner described eleven case 
studies of children with “an extreme autistic aloneness” (Kanner, 1943, p. 242).  
 In these case studies, eight of the eleven children learned language at either a normal or 
delayed age while the other three never acquired verbal language (Kanner, 1943). With the 
children who developed language, Kanner noted that their verbal communication did not 
“serve to convey meaning to others” (Kanner, 1943, p. 243). In these children with language 
difficulties, Kanner described that while the patients had remarkable facility learning to “name” 
things or repeat back rhymes, poetry, the alphabet, or prayers, these pieces of language had 
little meaning to them (Kanner, 1943). Additionally, Kanner described language that he termed 
“echolalia,” when the children would repeat whatever was said to them in a “parrot-like” 
fashion, either immediately or later (Kanner, 1943). In one case, for example, the child would 
state, “Now I will give you your milk” when expressing that he wanted more milk (Kanner, 1943, 
p. 244). This illustrated how the child with autism would simply repeat back what they had 
heard when it became associated with an outcome, such as receiving more milk. 
 Kanner also described the most profound symptom in ASD, the social impairments. 
Kanner framed discussion of the social impairments around the child’s need for being alone. For 
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example, he described how the children would ignore people in favor of toys he or she could 
directly control or play with. He also illustrated how the child sometimes had difficulty 
maintaining eye contact, and how they would sometimes view aspects of another’s body as 
tools or discrete entities (Kanner, 1943). For example, if a child was pricked by a pin, the child 
would be afraid of the pin, but not the person who pricked him or her (Kanner, 1943). 
 Kanner described some of the stereotyped and repetitive behavior found in autism in 
this report as well. For example he stated, “Once blocks, beads, and sticks have been put 
together in a certain way, they are always regrouped in exactly the same way, even though 
there was no definite design” (Kanner, 1943, p. 245). Here Kanner described the need for 
sameness and structure common in patients with ASD (Kanner, 1943). While Kanner did not 
describe the repetitive behaviors such as hand flapping, or body rocking he did state that the 
patients would sometime “exercise power over their own bodies by rolling and other rhythmic 
movements” (Kanner, 1943, p. 246). He also described some of the sensory issues common in 
ASD such as loud noises or moving objects bringing “minor panic” or anxiety (Kanner, 1943). 
Thus, in 1943 Kanner accurately described the condition we still term autism with many of the 
hallmark symptoms still associated with the disorder. 
 
Diagnostic Tools: 
 Two common tests used for diagnosis of ASD in the United States are the ADI and the 
ADOS. These tools are standardized, semistructured interviews for parents or children, 
respectively, which aim to identify if the child has the symptoms outlined in the DSM-IV-TR 
diagnostic criteria, and the severity these symptoms (de Bildt et al., 2004; Le Couteur, Haden, 
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Hammal, & McConachie, 2008). The ADI, or ADI-R (Autism Diagnostic Interview- Revised) is an 
“investigator-based interview for caregivers” (Lord et al., 1994, p. 660), while the ADOS is an 
“assessment of social interaction, communication, play, and imaginative use of materials for 
individuals suspected of having autism spectrum disorders” (Lord et al., 2000). Both of these 
tests have been found to have good validity and reliability (de Bildt et al., 2004). They have also 
been found to have lower specificity for low-functioning individuals, but the ADI-R may also 
have lower sensitivity for high-functioning individuals (de Bildt et al., 2004; Le Couteur et al., 
2008). Using these tools, it is somewhat likely to diagnose a low-functioning individual with 
autism when that diagnosis may not be accurate. Using just the ADI-R, it is also more likely to 
miss the diagnosis of high-functioning individuals with autism. When the ADI-R and ADOS are 
used in combination with each other and other tools, the diagnosis of the individual becomes 
much more accurate (de Bildt et al., 2004). 
 
Etiology: 
 Kanner described Autism in 1943, and its cause has been debated ever since. With the 
dramatic rise in ASD prevalence throughout the world, researchers have proposed various 
environmental factors that could be affecting this rising rate. One such widely reported 
hypothesis proposed by Wakefield in 1998 suggested that the measles, mumps and rubella 
(MMR) vaccination was correlated with the development of autistic symptoms in several 
children (Wakefield et al., 1998). After publication, this study gained publicity and created a 
great of deal of discussion and controversy. In addition, there was worry among clinicians that 
participation in vaccination programs would drop due to fear of autism (Taylor et al., 1999). 
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Subsequently, research concluded that the rising rates of ASD diagnoses did not match up with 
the rise in vaccination rates and that MMR vaccinations do not cause ASD symptoms (Chez, 
Chin, & Hung, 2004; D'Souza & Todd, 2003; Fombonne, 2008; Hviid, Stellfeld, Wohlfahrt, & 
Melbye, 2003; Peltola et al., 1998; Price et al., 2010; Taylor et al., 2002; Taylor et al., 1999). It 
was later proposed that thimerosal, a preservative used in the MMR vaccine containing 
mercury, may affect development of ASD symptoms. Some studies have illustrated that this is 
not the case, while others have pointed out that thimerosal has been almost entirely removed 
from MMR vaccinations but the prevalence of ASD is still increasing (Chez et al., 2004; 
Fombonne, 2008; Hviid et al., 2003; Price et al., 2010). Additionally, it appeared that there were 
significant conflicts of interest in Wakefield’s initial study as well as lack ethic committee 
approval, causing the initial publisher, The Lancet to fully retract the paper from “the public 
record” in 2010 (Lancet, 2010). It therefore appears that the correlation between age of the 
child when parents first notice autistic symptoms and age of receiving the MMR vaccination is 
what led to the highly popularized and incorrect findings (Taylor et al., 2002; Taylor et al., 
1999). 
 
Genetics: 
Recently the CDC observed that approximately 1 in 88 children in the United States have 
an ASD (CDC, 2012). Various sibling studies have observed significantly higher rates of ASD in 
siblings of affected children than the population at large. (Risch et al., 1999; Szatmari et al., 
2007). Even with the wide range of findings from these studies, the data thus indicate that 
there is likely a genetic component or risk factor involved in ASD. Twin studies have also shown 
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a concordance rate between 60% and 92%, further supporting the likelihood of a genetic 
influence (Szatmari et al., 2007). However, some empirical studies estimate that only 6-15% of 
ASD cases are due to genetic syndromes (Rossignol & Frye, 2012). Therefore, while genetics 
likely plays a role in ASD, it is probable that there are other factors at play in most ASD cases. 
 Various researchers all seem to agree that ASD is not caused by a single gene, but that is 
all that researchers seem to agree upon. For example much of the research identifying specific 
loci as the source of the disorder has not been replicated in follow up studies (Risch et al., 1999; 
Rossignol & Frye, 2012; Szatmari et al., 2007). Copy Number Variants (CNVs) have been 
implicated as possible risk factors for ASD as well as alterations in chromosome regions 1p, 2q, 
7q and 17q (Szatmari et al., 2007). Currently, it is widely felt that specific changes in 
chromosome region 7q are among the most common genetic risk factors for ASD (Risch et al., 
1999; Szatmari et al., 2007).  
However, the many loci identified also have diverse functions. Some studies have 
implicated genes encoding immune function (Patterson, 2009, 2011; Persico et al., 2012), while 
some studies have implicated genes encoding serotonin metabolism and neurotransmission, 
(Coutinho et al., 2007) and others have implicated genes encoding neurexins and neuroligins 
(Szatmari et al., 2007). Neurexins are proteins which induce postsynaptic differentiation in 
glutamatergic neurons while neuroligins are proteins which induce presynaptic differentiation 
in glutamatergic neurons (Szatmari et al., 2007). All of these genes appear to be risk factors for 
ASD to some degree. As these genes appear to have the same effect behaviorally, some 
researchers have suggested that a common pathway may exist on the molecular level to affect 
the behavior of the patients (Jyonouchi et al., 2011). 
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Immune System: 
 Another factor that appears linked to ASD is dysregulation within the immune system. 
For instance, one literature review found that of 437 publications describing the link between 
immune dysregulation or inflammation and ASD, 416 or 95% of these articles supported the 
association (Rossignol & Frye, 2012). Studies have also increasingly shown an association 
between genes encoding microglial and astrocyte activation with cytokine up-regulation in the 
central nervous system (CNS) and cerebral spinal fluid (CSF) in patients with ASD (Patterson, 
2009; Rossignol & Frye, 2012). Other studies have reported abnormal growth factors, the 
presence of autoantibodies in brain tissue, and abnormal biomarkers of immune function in the 
CNS or CSF in patients with ASD (Rossignol & Frye, 2012). 
 From a clinical standpoint, the connection between the immune system and ASD is 
feasible, as patients with ASD often have co-morbid conditions such as gastrointestinal 
symptoms or other immunodysregulations (Gondalia et al., 2012; Ibrahim, Voigt, Katusic, 
Weaver, & Barbaresi, 2009; Jyonouchi et al., 2008; Jyonouchi et al., 2011; Maenner et al., 2012; 
Mazurek et al., 2013). Additionally, recurrent infections are sometimes accompanied by 
exacerbations in ASD symptoms in some patients (Jyonouchi et al., 2008; Jyonouchi et al., 
2011). However, given the large interconnection between the immune system and 
neurodevelopment, some researchers question whether these abnormal immune functions are 
symptoms or causes of ASD (Persico et al., 2012). 
ASD becomes apparent very early in the life of patients, therefore researchers have 
looked to prenatal development for causes of this disorder. Some have argued that maternal 
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immune activity is one of the primary risk factors for ASD (Patterson, 2011). For example, 
Ciaranello and Ciaranello stated, “the principal non-genetic cause of autism is prenatal viral 
infection”(Ciaranello & Ciaranello, 1995). Studies supporting this hypothesis have shown that 
prenatal exposure to rubella or cytomegalovirus is associated with an increased risk for ASD 
(Patterson, 2009). In an animal model examining how a human influenza infection in pregnant 
mice can affect their children, it was found that the young mice displayed behavioral 
abnormalities such as deficits in social interaction, prepulse inhibition and open field and novel 
object exploration (Patterson, 2009). These behaviors are thought to be associated with ASD 
symptoms in humans. Additionally, brain abnormalities in these mice were also found in the 
hippocampus and cortex. These abnormalities included a spatial restriction deficit in Purkinje 
cells, a neuropathology thought to be common in autism (Patterson, 2009). These mice also 
experienced transcription alterations and abnormalities in serotonin production in the 
cerebellum, implicating an epigenetic influence (Patterson, 2009). 
High-fat, and specifically high omega-6 intake, has been shown to have numerous 
deleterious effects, including activation of pro-inflammatory responses (Ramsden et al., 2011; 
Shankar et al., 2012). It is therefore possible that the increased prevalence of ASD may be 
associated with the rise in pro-inflammatory diets in mothers. However, so many factors affect 
prenatal neurodevelopment that further research is required to make this connection. 
 
Other Hypotheses: 
Serotonin has also recently been investigated as to its effect on ASD occurrence 
(Coutinho et al., 2007; Croen, Grether, Yoshida, Odouli, & Hendrick, 2011; Kane et al., 2012; 
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Levitt, 2011; Sato, 2013). Evidence has arisen that neurotransmitters, such as serotonin, 
glutamate and GABA, may impact neurodevelopment during the first trimester in humans 
(Levitt, 2011). Serotonin is thought to have an effect on neuronal migration, axonal guidance 
and determining the trajectory of thalamocortical pathways (Kane et al., 2012). The use of 
selective serotonin reuptake inhibitors, especially during the first trimester, may be a risk factor 
for ASD (Croen et al., 2011). However, Croen et al. have noted that depression alone can also 
increase risk for poor developmental outcomes and therefore the findings of this study should 
be interpreted cautiously (Croen et al., 2011).  
Further support for this hypothesis has come from genetic studies. The HTR5A gene 
alone was found to be a significant risk factor for the development of ASD symptoms (Coutinho 
et al., 2007). In this study, a three-locus model of a synergistic effect between ITGB3 and 
SLC6A4 with an additive effect of HTR5A, was additionally identified as a contributing risk factor 
for ASD (Coutinho et al., 2007). HTR5A is a serotonin receptor gene, SLC6A4 is a serotonin 
transporter gene and ITGB3 encodes the integrin β3 subunit (Coutinho et al., 2007). This study 
thus implicated a possible link between serotonin metabolism and serotonin transportation 
with ASD. 
 One large population-based study has recently described a connection between early 
pregnancy folic acid supplement use and a decreased risk for ASD in the child (Berry et al., 
2013; Schmidt et al., 2012; Surén et al., 2013). The study found 4-week early pregnancy usage 
of 400 µg or more per day decreased the risk of the child being later diagnosed with ASD (Berry 
et al., 2013; Surén et al., 2013). This study suggested that the critical exposure interval for this 
effect was between 4 weeks and 8 weeks after the start of pregnancy (Surén et al., 2013). 
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Women taking folic acid in the critical exposure interval were more likely to have a college 
education, have a planned pregnancy and to be nonsmokers (Surén et al., 2013). While this may 
have affected the child’s risk for ASD, it was noted that mothers taking fish oil supplements had 
a similar profile, but did not see the reduction in ASD risk (Surén et al., 2013).  
 
Therapies and Interventions: 
 ASD is a complex disorder and thus the therapies for this disorder are vast. Risperidone 
and Aripiprazole are the two pharmaceutical agents currently approved by the FDA to treat ASD 
symptoms. While these pharmaceuticals have been shown to have a beneficial effect for some 
patients, most interventions for individuals with ASD include or are primarily focused on 
behavioral therapies. 
Risperidone and Aripiprazole, are both considered atypical antipsychotics. Risperidone 
has been shown to reduce many aberrant behaviors in children with ASD as well as improved 
social responsiveness (Canitano & Scandurra, 2008; Nagaraj, Singhi, & Malhi, 2006; Wei et al., 
2011). However, it has also been shown that a large side-effect of taking Risperidone is 
increased appetite and weight gain (Nagaraj et al., 2006; Ratzoni et al., 2002). Aripiprazole has 
also been shown to decrease aberrant behaviors in children with ASD and in some others with 
other developmental disorder, with side-effects that include sleepiness and weight gain (Ching 
& Pringsheim, 2012; Farmer & Aman, 2011; Marcus et al., 2009; Owen et al., 2009; Valicenti-
McDermott & Demb, 2006). 
Behavioral based therapies ASD include programs such as early intensive interventions, 
TEACCH and EAAT. However, TEACCH and EAAT are often used for children over six years old, 
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after early interventions are no longer possible (Bass et al., 2009; "Training and Education of 
Autistic and Related Communication Handicapped Children (TEACCH)," 2013). While these 
therapies are very effective, the most effective treatment for individuals with ASD has been 
shown to be early intensive intervention (Francis, 2005; Rogers, 1996; Rogers & Vismara, 2008). 
In early intensive interventions at ages 2-4 years, the patients experienced the greatest 
improvement when the intervention included at least 15 hours of treatment per week and the 
child to adult ratio was 1:2 or more (Rogers, 1996). However, despite the variety of early 
intensive interventions, most of the treatments examined in one review reported significant 
acceleration in developmental rates, significant IQ gains, significant language gains, improved 
social behavior and decreased ASD symptoms in patients after treatment (Rogers, 1996). 
Additionally, studies have shown that children who began intervention between 2 and 4 years 
of age benefited more than older children entering the same program (Rogers, 1996). 
It has also been shown that those who do not go through an early intensive 
intervention, but go through another behavioral intervention such as TEACCH later in life, have 
improved ASD symptomology and experience structural changes in white matter tracts such as 
the uncinate fasciculus (Keel, Mesibov, & Woods, 1997; Mesibov & Shea, 2010; Panerai et al., 
2009; Pardini et al., 2012; Tsang, Shek, Lam, Tang, & Cheung, 2007). Thus, while patients 
entering therapy when they are older may not receive all the benefits seen in early intensive 
interventions, significant improvements can still be made. The TEACCH program uses the visual 
learning strengths common in those with an ASD as well as their attention to detail and routine 
in order to effectively help individuals with ASD learn various adaptive skills (Mesibov & Shea, 
2010). The TEACCH approach to educating children with ASD addresses the certain difficulties 
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inherent in the population such as poor organization or sequencing, sensory processing, and 
social-communication skills. The TEACCH approach assumes that these deficits are directly 
linked to the difficult behaviors observed in this autism population and thus are the areas of 
focus in TEACCH based therapies (Cox & Schopler, 1993). TEACCH has been shown to effectively 
improve adaptive behaviors in the patients and even to decrease depressive symptoms in the 
caregivers of children with ASD (Mesibov & Shea, 2010).  
 Another intervention that has begun to show beneficial results to those with ASD is 
EAAT. One type of EAAT is therapeutic horseback riding.  Patients who received therapeutic 
horseback riding have been shown to have improvement in their inattention and distractibility, 
improved social responsiveness and improved social motivation (Bass et al., 2009). Therapeutic 
horseback riding has also been shown to improve irritability, lethargy, stereotypic behavior, 
hyperactivity and expressive language skills when compared to a control group made up of 
children on the waitlist for this program (R. L. Gabriels et al., 2012). One recent study has 
shown that participants in a therapeutic horseback riding program saw significant gains in social 
interaction and a significant decrease in ASD symptomology. However, these results were not 
maintained without further therapeutic horseback riding (Ward et al., 2013). 
Use of Picture Schedules in Medical Settings: 
A variety of challenges have been documented regarding medical procedures and the 
ASD population. Thus the present study and former studies have examined how to improve 
medical care for individuals with ASD. In order to decrease cost and anxiety, the TEACCH 
practice of using picture schedules in education has recently been adapted for use in various 
medical settings. Picture schedules are common tools used in educational, community and 
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home settings and have been shown to decrease anxiety, decrease problem behaviors and 
increase compliance with the task at hand (Chebuhar et al., 2012). However, very little research 
has been done using picture schedules in medical settings (Chebuhar et al., 2012). 
Various studies have illustrated the need for a strategy such as a picture schedule. For 
example some studies looking into the cost of health care for children with and without ASD 
and suggest that costs are significantly higher for children with ASD (Flanders et al., 2013; 
Hudson, 2006). A national health care sample revealed that children with autism spent 
significantly more time with the physician during visits (31.9 minutes) compared to a general 
population of children without ASD, depression or an intellectual disability (15.8 minutes) 
(Liptak, Stuart, & Auinger, 2006). Another study showed that medical specialists and primary 
care providers tended to demonstrate outdated beliefs about autism (Liptak, Orlando, et al., 
2006). Additionally children with ASD have been shown to visit physicians more (8.0 vs. 2.5 
visits annually) and have more medication prescribed annually (21.8 vs. 5.9) than children with 
mental retardation, indicating the high amount of contact children with ASD have with health 
care settings (Liptak, Stuart, et al., 2006).  
Several studies aimed at improving healthcare management and cooperation for 
children with ASD have been done within the dental field, many using picture schedules to 
increase compliance. One study evaluated the effectiveness of preparing children with ASD for 
a dental exam using a picture book illustrating a dental visit to children with autism ages 3.3 to 
6 years (Bäckman & Pilebro, 1999b). This picture book contained photographs of dental exam 
items and the steps that would be involved in the upcoming dental visit. Cooperation with 
procedures was “superior” for those in the treatment group exposed to the picture book in 
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comparison to those in the control group who were not shown the picture book (Bäckman & 
Pilebro, 1999b).  
Another study examined using priming videos and still photos to teach five children 
ages 3-5 years with PDD-NOS or autism compliance with dental exams (Cuvo et al., 2010). 
Results indicated that children were able to complete steps of the dental exam when 
distracting stimuli were present and reinforcement was used. Children were also able to 
maintain compliance for up to one month after the end of training (Cuvo et al., 2010). 
However, as a package of training components was used, no individual component’s efficacy 
could be assessed.  
Needle phobia for an 18-year old diagnosed with Type 2 diabetes, autism and mental 
retardation was also assessed in a particular case study (Shabani & Fisher, 2006). This case 
study found success in gradually increasing the young man’s exposure to the fear-evoking 
stimulus and reinforcing the desired behaviors. The participant’s mother was able to 
successfully obtain daily blood samples post-intervention (Shabani & Fisher, 2006).  
Another study expanded the use of the visual pedagogy and evaluated the effectiveness 
of employing this technique for 12 months on improving oral hygiene/tooth brushing behaviors 
in 14 children with autism ages 5 to 13 years (Pilebro & Bäckman, 2005). Clinical examinations 
of the child’s teeth were made prior to the introduction of the visual pedagogy and then again 
after 8 and 12 months of treatment. This treatment included usage of photos describing steps 
for brushing teeth. Prior to the study, parents reported having difficulty helping their child 
maintain good oral hygiene, whereas most parents found this to be easier after the study. All 
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children had visible plaque reduction after 12 months of the study (Bäckman & Pilebro, 1999b; 
Pilebro & Bäckman, 2005).  
The challenges of conducting an adequate dental exam and maintaining safe dentist-
patient interactions were addressed in a study by Lowe and Lindeman in 1985. They did this 
through using a modeling reinforcement system during dental exams with 20 patients with ASD 
and 20 non-autistic matched controls (ages 3 to 30 years) (Lowe & Lindemann, 1985). Thorough 
and successful completion of exams was quantified and the behavior management treatment 
strategies were used with both population groups. Following the introduction of this approach, 
“successful exams” were obtained in 85% of the participants with autism on their first 
appointment. “Successful exams” were obtained in 90% of the non-autistic participants on their 
first appointment (Lowe & Lindemann, 1985). 
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Methods: 
Participants: 
This study attempted to recruit eighteen existing patients from the Barbara Davis Center 
for Diabetes between the ages of 3 and 17 diagnosed with ASD and either Type I or Type II 
diabetes. These individuals previously agreed to be contacted for research purposes including, 
but not limited to the proposed study. Caregivers of these potential subjects were screened 
over the phone and asked about the child’s irritable and stereotypic behaviors during routine 
blood draws using the ABC-C. If the child’s score was 11 points or higher on this checklist, then 
they were invited to participate in the study. The incentive offered to parents to participate in 
the study was a free nonverbal IQ test with a corresponding report. 
Two participants, subjects A and B, who were age 14 and 10, respectively, participated 
in the study. Both subjects had previously been diagnosed with an Autistic Disorder or 
Asperger’s Disorder. Additionally, subjects A and B were rated by their caregivers as either 
having “Poor Cooperation” or being “Completely Uncooperative” with their previous blood 
draw on a 4-point scale of cooperation.  
 
Measures: 
 Primary caregivers were asked to complete child behavior questionnaires. The primary 
caregiver is defined as the adult living with the child who is most familiar with the participant’s 
behavior. The same caregiver completed all forms for each participant. 
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Leiter International Performance Test-Revised (Leiter-R):  
The Leiter-R is a reliable and valid measure of non-verbal intelligence for ages 2 years to 
20 years, 11 months (Roid & L.J., 1997). This measure of nonverbal problem-solving and 
learning is commonly used to assess IQ in children with ASD or other language-impairments, as 
it does not require verbal instructions or responses for administration or extensive fine motor 
skills. However, it can also be used to assess the nonverbal cognitive abilities of children who 
have fluent language. The Brief IQ version of this test was chosen to limit the assessment 
demands of the child and because the correlation between the Leiter-R Brief IQ score and the 
Full Scale IQ scores of the WISC-III is reported as 0.85 (Roid & Miller, 1997). The Leiter-R was 
administered to all subjects participating in this study.  
 
Social Communication Questionnaire (SCQ):  
 The SCQ, formerly known as the Autism Screening Questionnaire, is a parent-caregiver 
completed measure that assesses the presence of behaviors common to an autism spectrum 
disorder (Rutter, Bailey, & Lord, 2003). The SCQ is a 40-item survey that is based on the Autism 
Diagnostic Interview-Revised (ADI-R). One study has shown that the SCQ has an 82% sensitivity 
and 88% specificity (Johnson et al., 2011). The SCQ is thus a good diagnostic tool for detecting 
ASD. Though the risk of false positives is present when using the SCQ, this questionnaire was 
used solely to confirm an already diagnosed condition. The SCQ was completed by the primary 
caregiver during the screening. 
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Cooperation Scale: 
The primary caregiver rated the child’s of level of cooperation with the subject’s 
previous blood draw administration at the Barbara Davis Center both during the phone screen 
as part of the screening and at the informed consent. The caregiver and researcher also 
independently rated the child’s level of cooperation immediately following the blood draw 
administration. This scale was modified from a shorter version used to assess cooperation in 
dental exams (Forsberg, Quick-Nilsson, Gustavson, & Jagell, 1985). (See Cooperation Scale 
below) 
 
  
HOW COOPERATIVE WAS THE CHILD DURING TODAY’S PHYSICAL EXAM? 
0 = No problems with cooperation 
1 = Minor problems with cooperation: child shows mild behavior problems 
and/or anxiety symptoms 
2 = Poor cooperation: Child’s behavior problems and/or anxiety symptoms 
requires that the medical staff have to spend extra time and effort to 
manage the child and complete the exam 
3 = Completely uncooperative: Exam is not possible due to child’s behavior 
problems and/or anxiety symptoms 
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Aberrant Behavior Checklist-Community: 
The Aberrant Behavior Checklist-Community (ABC-C) is a 58-item symptom checklist for 
assessing behavior problems in people with developmental disabilities (Aman, Burrow, & 
Wolford, 1995). The ABC-C yields five distinct factors: Irritability, Hyperactivity, Lethargy, 
Stereotypy, and Inappropriate Speech. This test was originally developed for use with 
individuals with mental retardation, but has since become a common tool used within ASD 
populations as well (Brinkley et al., 2007; Hill, Powlitch, & Furniss, 2008). The ABC-C has also 
been shown to have good interrater and test-retest reliability (Aman, Singh, Stewart, & Field, 
1985; Aman, Singh, & Turbott, 1987). 
Only the Irritability and Stereotypy factor scores were used in this project to assess the 
presence of behaviors such as aggression, self-injury, tantrums, screaming, and repetitive, 
nonfunctional body movements (see appendix II). The caregiver completed the baseline 
measure for the ABC-C based upon the four weeks of the subject’s behavior leading up to the 
study. This was compared to the ABC-C score given by the caregiver during the blood draw 
procedure. The researcher also completed the ABC-C based upon the subject’s behavior during 
the blood draw. 
 
Procedure: 
Screening: 
After approval from the Institutional Review Board, those diagnosed with both an ASD 
and either type I or type II diabetes were called by the undergraduate investigator. Caregivers 
- 26 - 
 
interested in the study were provided a brief summary of the study over the phone and asked 
several questions specific to study inclusion and exclusion criteria (see Appendix III).  
schedule intervention. 
Informed Consent:  
Participants who met initial study criteria were scheduled for a screening visit at the 
hospital clinic prior to the subject’s blood draw. Participants’ DSM-IV diagnosis of autism or 
Asperger’s was confirmed using information from the Social Communication Questionnaire 
(SCQ) (Rutter et al., 2003). Participants’ nonverbal intelligence was evaluated using the Leiter-R 
Brief IQ (Roid & Miller, 1997). Participants with standard Leiter-R scores less than 40 would 
have been excluded due to concerns that such individuals might not understand the visual. The 
subject’s baseline ABC-C score was ascertained from the parents based on the previous four 
weeks of behavior. Subject cooperation in the previous blood draw was also ascertained from 
the cooperation scale completed by the caregiver. The subject and caregiver were also asked 
questions pertaining to their child’s exposure to visual schedules and demographic information 
using the Child and Caregiver Information Form. Nonverbal IQ was then measured 
administering a Leiter-R IQ test.  
Intervention:  
Subjects A and B both went through their routine blood draws after the initial screening. 
A physical examination accompanied the blood draw. Before the blood draw, the subject briefly 
waited in the waiting room before going into a room accompanied by one or two nurses, the 
researcher and the caregiver. The BDC nurses, who were trained to run blood draws and had 
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agreed to take part in this procedure, administered the blood draw while the researcher 
presented the picture schedule reinforcement system to the subject. 
The picture schedule reinforcement system consisted of a picture schedule booklet (see 
appendix I) accompanied by a reinforcement of dried apple treat rewards. The nutritionist at 
the BDC recommended that a quarter cup of dried apples would be ideal so that the subject did 
not require an insulin injection following the treatment. The 8 ½” x 11” picture booklet 
contained a total of 6 laminated color photos of the object being used in the exam or a task 
designed as a distraction tool. Plastic baggies were placed behind each page to hold the reward. 
Pictures were distinct color-prints of each small step of the physical exam visit without 
irrelevant details. Simple and concrete descriptions were written above each picture to 
describe what the child was expected to do in the exam (sit on table, put on armband, etc.). 
After each step, the subject received a portion of reward. During the blood draw, caregivers 
and the researcher rated the participants using the ABC-C and the cooperation scale. After the 
blood draw the parents were asked in an exit interview what they thought was beneficial in the 
procedure and what could be changed for future studies. 
The steps outlined in the booklet were: 
1. Time for Blood Test 
2. Rest on Table 
3. Put Arm Band On 
4. Clean Skin and Hold Still 
5. Count Faces 
6. All Done with Blood Test! 
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Results: 
 Blood draw procedures were done to completion in both subjects with no adverse 
reactions or effects (see figure 1 for demographics). Subjects A and B were both male and four 
years apart in age. These subjects had very different levels of functionality as represented by 
their SCQ and Nonverbal IQ score. The cutoff SCQ score for ASD is 15. The ABC-C is scored by 
adding up the individual scores from each behavior on the questionnaire (see appendix II). The 
cooperation scale is a scale from 0 to 3. The higher the score, the less cooperative the subject 
was with the procedure. 
Characteristic Subject A Subject B 
Age 14 10 
Gender Male Male 
Leiter-R IQ Score 71 137 
SCQ 27 15 
Caregiver ABC-C Baseline 26 19 
Caregiver ABC-C Blood draw 0 1 
Researcher ABC-C Blood draw 7 0 
Caregiver Cooperation Scale 
Previous Blood Draw 
2.5 1 
Caregiver Cooperation Scale 
Present Blood Draw 
1 0 
Researcher Cooperation Scale 
Present Blood Draw 
1 0 
Figure 1- 
Summary of collected data 
 
Subject A had the blood draw procedure done immediately following the screening 
process. For this subject, the caregiver reported that getting the needle into the subject’s arm 
was the aspect of the blood draw procedure that was most difficult, and why the last blood 
draw attempted with the subject was not able to be completed at the Barbara Davis Center. 
This blood draw was accomplished very rapidly by the two nurses administering the blood 
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draw. After the procedure the caregiver stated in the exit interview that the booklet was “very 
helpful” for the subject. Of note, the subject initially requested pineapples rather than apples 
for a reward. The subject also held each piece of dried apple in his hand to “save for later.” 
Subject A saw a large decrease in his ABC-C score between baseline conditions and the present 
blood draw (see figure 3). He also saw a decrease in his cooperation scale score from the 
previous blood draw to the present blood draw. (see figure 5). 
Subject B was screened before the physical examination. The blood draw was 
administered following completion of the physical exam. For this subject only one nurse was 
present. The subject maintained attention towards the picture schedule booklet throughout 
most of the procedure and smiled most times he received the reward. This subject was given a 
baggie containing a piece of a dried apple. After the procedure, in the exit interview the 
caregiver commented that the booklet was helpful and that “he really seemed to enjoy the 
bags of dried apples.” She also stated that the pictures were “pretty boring”, that maybe a 
word search could have been used instead of the counting faces task. She also stated that 
quarters could potentially be a good reward to replace the dried apples. Subject B saw a large 
decrease in his ABC-C score between baseline conditions and the present blood draw as scored 
by the caregiver (see figure 4). He also saw a small difference between his cooperation scale 
scores from the previous blood draw to the present blood draw as scored by the caregiver (see 
figure 6).  
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Figure 2- 
Average ABC-C Scores 
 
 
Figure 3- 
Subject A ABC-C data 
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Figure 4 –  
ABC-C Data comparing baseline and blood draw scores 
 
 
Figure 5 – 
Subject A Cooperation Scale Data 
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Figure 6- 
Subject B Cooperation Scale data  
 
There was found to be significant decrease in ABC-C scores between the caregiver 
baseline and treatment scores using a standard t-test (p=.007). This decrease indicated that 
overall aberrant behavior severity was lower during the blood draw than in baseline conditions 
(see figure 2). Additionally, the caregiver ABC-C score did not differ significantly from the 
researcher ABC-C score (p=.27). While there was no significant difference between the previous 
blood draw cooperation score and the treatment cooperation score, there appeared to be a 
trend toward a decrease in the score (more cooperative) from baseline to treatment conditions 
(see figures 5 and 6). 
Discussion: 
 Both subjects had successful blood draws and both appeared to benefit from the use of 
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at the Barbara Davis Center. A significant reduction from the baseline ABC-C scores to the 
treatment was also noted. Hence, the picture schedule reinforcement system’s marriage of 
TEACCH picture schedules and ABA positive reinforcement may have benefited these subjects. 
This strategy therefore shows promise as both caregivers reported that the picture schedule 
reinforcement system was helpful. 
 In this study, the subjects’ functionality was wide. In both the SCQ, and the Leiter-R, the 
subjects’ scores were wide (see table 1). The cutoff score for ASD when using the SCQ is 15, 
while the maximum score a subject can receive on this questionnaire is 40. Subject B scored a 
15 on this measure, while subject A scored a 27. Higher scores on the SCQ are associated with 
lower social communication skills, which can be a symptom of ASD (Johnson et al., 2011). 
Additionally, subject A scored a 71 on the Leiter-R nonverbal IQ test while subject B scored a 
137. The population average for the Leiter-R is approximately 100 with a standard deviation of 
15 (Roid, 1997). When taken together these scores illustrate the difference in functionality 
between the two subjects. It therefore appears that the picture schedule reinforcement system 
may be able to aid individuals with varied severities of ASD. From clinical observations, it 
appeared that while both subjects benefited, different aspects of the picture schedule 
reinforcement system were beneficial to different subjects. 
For example, subject A was not able to complete the blood draw attempted before the 
present study due to irritability. However, this blood draw was able to be accomplished with no 
adverse reactions. Subject A largely did not utilize the picture schedule booklet until the nurses 
were finding the vein to insert the needle. At this point in the procedure, he participated in the 
“counting faces” task in the booklet as opposed to engaging in conversation with the nurses. As 
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his caregiver stated that this was the most difficult part of the blood draw for the subject in the 
last attempted blood draw. It appeared that this strategy may have played a part in easing the 
administration of the procedure for this individual.  
While the distraction task was helpful for subject A, he did not appear to pay much 
attention to the picture schedule during the remaining portion of the procedure. One possible 
reason for this was the subject’s lack of interest in the dried apple reward. Subject A, once 
presented with the piece of dried apple requested pineapple instead of apples. As the subject 
also did not eat the apple until coaxed to do so by one of the nurses, it appears that this system 
of rewards was ineffectual. A way to improve this in future studies would be to have the 
caregiver bring in the preferred treat for the individual. 
In comparison, subject B seemed to enjoy and use a greater deal of the picture 
schedule. Subject B may have paid more attention to the picture schedule due to his higher 
functionality, but the subject also seemed to enjoy the rewards more. One of the differences 
between the administrations of these two procedures was that subject B was given the baggie 
containing the dried apple treat while subject A was only given the dried apple treat. For 
subject B, the baggie had to be removed via Velcro from the back of a page of the booklet. By 
the end of the procedure, the subject smiled every time he heard the sound of the Velcro 
pieces being torn apart and saw the researcher taking the bag being taken off the booklet. 
Subject B did not particularly seem to like dried apples, but he did enjoy receiving the bag. One 
possibility is that the subject simply liked plastic bags or Velcro. Another possibility is that as the 
sound of the Velcro became associated with receiving a reward, the subject connected rewards 
with the sound. 
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A major limitation of this study was the small sample size (n=2). Due to the small sample 
size, this study does not provide strong evidence to support this picture schedule reinforcement 
system as a strategy for use with those with a dual diagnosis of ASD and diabetes. While the 
literature supports the use of picture schedule for use within dental and medical settings, this 
study illustrates that it is possible that the same tool may be helpful for individuals with ASD in 
adverse procedures such as blood draws (Bäckman & Pilebro, 1999b; Chebuhar et al., 2012; 
Cuvo et al., 2010; R. Gabriels et al., 2013). This study illustrates that further research should be 
done to examine the utility of this strategy or other similar strategies aimed at aiding those 
with an ASD go through difficult, invasive, or even common medical procedures. 
The most important addition to any future study would be a larger sample size. One 
possible way to increase the sample size would be to broaden the inclusion criteria to include 
any individuals with ASD who receive regular blood draws. The population with both ASD and 
diabetes is small, but the population with ASD who have received blood draws is a great deal 
larger. Also, as this study found it very hard to incentivize individuals to be a part of this study, 
it would be advisable to offer something akin to monetary reimbursement for the time spent in 
this study. As costly as standardized testing for individuals with ASD is, offering free testing 
does not seem to be a good enough incentive to recruit the numbers originally desired in this 
study. By increasing the sample size, future studies could increase the power of the study and 
allow the researchers to examine this approach more thoroughly.  
A potential addition to future studies would be the inclusion of treats or rewards 
brought by parents for the expressed purpose of the picture schedule reinforcement system. 
This could potentially give subjects more motivation to comply with the picture schedule and 
- 36 - 
 
the blood draw as a whole. In this study, the picture schedule gave the subjects a structure and 
task to follow, but the reward was meant to increase the motivation of the subjects to 
accomplish each step of the task. As the subjects did not have their ideal reward for this 
procedure, a way to increase compliance with the picture schedule, and thus decrease anxiety 
in patients, would be to increase the reward’s value to the subject. 
Future studies could also potentially use different picture schedule books to see exactly 
what variables affect participation among the subjects. The pictures within the book could be 
altered to include different subject genders, location, lighting, etc. to examine whether these 
variables affect the utility of the booklet. As time with health care individuals can be costly, 
another variable that would be useful to examine in future studies would be the amount of 
time the procedure takes. This could examine to what degree this approach could reduce time, 
and therefore the health care costs for individuals with ASD. 
Another limitation to this study is the manner in which the ABC-C was used to measure 
irritable and stereotypic behaviors of the subjects. The baseline measure asked caregivers to 
rate the severity of irritable and stereotypic behaviors over the previous four weeks leading up 
to the blood draws. The treatment ABC-C measure asked parents to rate the severity of the 
same behaviors through the course of the blood draw. Thus the comparison is between ABC-C 
scores rating four weeks of behavior to a procedure that generally takes less than a half hour. 
According to previous study done by Gabriels et al. the average decrease in the ABC-C 
irritability and stereotopy subscore was 10.2 for the group using the picture schedule and 1.1 
for the control group (R. Gabriels et al., 2013). The observed decrease seen in the present study 
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was much larger, indicating the importance of comparing ABC-C scores taken from similar time 
lengths. 
Therefore, a control blood draw would also be beneficial for any future study examining 
the effects of picture schedule reinforcement systems in medical procedures. In this study, the 
baseline scores were based entirely off of caregiver reports depending upon the caregiver’s 
memory of the child’s behavior over the previous four weeks and of the child’s cooperation 
with their previous blood draw. In future studies, a way to eliminate this would be to include 
two blood draws, a control blood draw and a treatment blood draw. By randomizing the 
subjects to either receive the control or treatment blood draw first, the researchers would be 
able to minimize further bias from the subjects. 
Thus a possible future study design would be as follows: Subjects recruited would be: 
children between the ages of 3 and 17, diagnosed by a research reliable psychologist with an 
ASD, have received a blood draw within the past 2 years, and planning on receiving a blood 
draw as part of their routine medical care. Monetary compensation would be given to subjects 
for participation as well as a summary of the tests provided. The subjects could be screened 
using the same screening procedure used in the present study, possibly adding an additional 
diagnostic tool such as the ADOS to further confirm the diagnosis of the subjects. Subjects could 
additionally be kept blind to the aims of the study to reduce bias. After the subject has been 
screened they could be randomized into one of two groups. The subjects should be randomized 
based upon their ABC-C scores to ensure that the more irritable subjects are not concentrated 
in a single group. Subjects should also ideally be stratified by age and ASD symptom severity as 
measured by the SCQ, ADOS, or another tool. A matched subject design could also be 
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employed, matching subjects to others with the same comorbid conditions, to minimize the 
potential confound of comorbid diseases. 
Both groups would go through two blood draws separated by at least six months. The 
first group would receive the picture schedule reinforcement system at the first blood draw and 
go through blood draw without the system in the second blood draw. The second group would 
go through the first blood draw without the system and use the system on the second blood 
draw. During each blood draw procedure, the caregiver and an independent rater blind to the 
aims of the study would rate the child on the ABC-C and cooperation scale. Additional scales 
monitoring the behavior of the subject could also be used here. The independent raters could 
also measure the time the procedure takes, as it could help illustrate the effectiveness of the 
system. Ideally, having two independent raters who have been trained to be consistent in the 
ABC-C and cooperation scales would be best. In this way, each rater would be assigned to rate 
either just the blood draws using the picture schedule reinforcement system, or the blood 
draws not using the system. Therefore, the rater’s blindness to the aims of the study would be 
maintained. The subject’s blood draw without the system would thus act as a control group. In 
this way, the effectiveness of the picture schedule reinforcement system could be measured 
using behavioral measures and time in a double-blinded control group study. As the literature 
does not appear to have any studies examining the efficacy of picture schedules using blinded 
control group studies, a study such as this could be enormously beneficial to the ASD 
community. 
This study could also be repeated to examine other variables with potentially profound 
effects on the blood draw procedure. Comparing blood draws using the picture schedule 
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reinforcement system could be compared to blood draws using a picture schedule with no 
reward. The number of nurses tending to the subject could also be altered to examine how 
important this variable is. 
Communication impairment is one of the three primary symptoms of (APA, 2000; WHO, 
2004). Given this, it appears that visual instructions are sometimes incorporated better than 
verbal or written instructions (Bryan, 2000). Picture schedules, such as the one used in this 
study, are becoming increasingly understood as useful tools for individuals with ASD (Bäckman, 
1999; Bryan, 2000; Chebuhar, 2012; Pilebro, 2005). 
Overall this study provides useful circumstantial data supporting the use of a picture 
schedule reinforcement systems for blood draw procedures with individuals with ASD and 
diabetes. The study was limited by the sample size and confounds within the ABC-C data 
collection. Within education and the medical field it is becoming increasingly important to 
examine novel tools to aid individuals with ASD. While there is not enough power in this study 
to support picture schedule reinforcement systems, it illustrates that this strategy could have 
profound benefits for individuals with a dual diagnosis of ASD and diabetes or any individual 
with ASD who goes through blood draws. 
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Time for Blood Test  
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Put Arm Band On   
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Clean Skin and Hold Still 
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Count Faces 
  
 
(Give Reward) 
 
 
 
(Give Reward) 
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All Done with Blood Test! 
 
 
 
 
 
Get Big Prize 
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Aberrant Behavior Checklist – Irritability/Stereotypy Items 
I. Please rate the child’s behavior during the blood draw. For each item, decide whether the behavior is a 
problem and circle the appropriate number.  
 0= not at all a problem   1=the behavior is a problem but slight in degree 
 2= the problem is moderately serious 3=the problem is severe in degree 
 
02. Injures self on purpose           0            1            2              3 
04. Aggressive to other children or adults (verbally or physically)      0            1            2              3 
06. Meaningless, recurring body movements         0            1            2              3 
08. Screams inappropriately                          0            1            2              3 
10. Temper tantrums/outbursts          0            1            2              3 
11. Stereotyped behavior; abnormal, repetitive movements       0            1            2              3 
14. Irritability and whiny           0            1            2              3 
17. Odd, bizarre in behavior              0            1            2              3 
19. Yells at inappropriate times          0            1            2              3 
25. Depressed mood           0            1            2              3 
27. Moves or rolls head back and fort repetitively        0            1            2              3 
29. Demands must met immediately             0            1            2              3 
34. Cries over minor annoyances and hurts         0            1            2              3 
35. Repetitive hand, body, head movements         0            1            2              3 
36. Mood changes quickly           0            1            2              3 
41. Cries and screams inappropriately             0            1            2              3 
45. Waves or shakes the extremities repeatedly        0            1            2              3 
47. Stamps feet or bangs objects or slams doors        0            1            2              3 
49. Rocks body back and forth repeatedly         0            1            2              3 
50. Deliberately hurts himself/herself             0            1            2              3 
52. Does physical violence to self            0            1            2              3 
57. Has temper outbursts or tantrums when he/she does not get own way    0            1            2              3 
modified form 
©1994 Slosson Educational Publications, Inc. 
P.O. Box 280, East Aurora, New York 14052 
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Phone Screen Questions 
Participant Information 
 
I. Circle the item that best applies to how cooperative your child is typically during blood draws.   
 0 = No problems with cooperation 
 1 =  Minor problems with cooperation: child shows mild behavior problems and/or anxiety symptoms 
 2 = Poor cooperation: Child’s behavior problems and/or anxiety symptoms requires that the medical   
 staff have to spend extra time and effort to manage the child and complete the blood draw 
 3 = Completely uncooperative: Blood draw is not possible due to child’s behavior problems and/or  
  anxiety symptoms 
 
Comments:            
            
 
II. List any aspects of a blood draw that your child is compliant with. 
             
            
 
III. List the aspects of a blood draw that are the most difficult for your child. 
             
            
 
IV. List any sensitivities (e.g., sights, sounds, etc.) your child has that we should know about. 
             
            
 
V. List any special interests or treats your child finds motivating.  
             
            
 
 
 
 
